SCHEMBL24323158

SCHEMBL24323158

Cc1cccc(C)c1-c1cc(OCCNCC(C)C)nc(NSc2cccc(C(=O)O)c2)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 2/20 0.35
SCN1A P35498 1/20 0.33
SCN2A Q99250 1/20 0.33
SCN3A Q9NY46 1/20 0.33
NPC1 O15118 3/20 0.32
RAB9A P51151 3/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
NR1H4 Q96RI1 4/20 0.31
CAMK2D Q13557 1/20 0.31
HSD17B10 Q99714 2/20 0.31
MAPT P10636 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
MITF O75030 1/20 0.31
NFKB1 P19838 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31
PAX8 Q06710 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24323828 0.89 PIK3CD (0.34) KDM4EALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL26846380 0.85 SCN4A (0.34) ALDH1A1SCN1ASCN2ASCN3ANPC1
SCHEMBL22509294 0.84 AAK1 (0.34) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL24298810 0.84 AAK1 (0.34) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL24298312 0.83 EGFR (0.36)
SCHEMBL29600374 0.83 WDR5 (0.40) ALDH1A1SMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL24323678 0.83 NR1H4 (0.33) KDM4EALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL24323163 0.83 WDR5 (0.40) ALDH1A1SMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL24326406 0.82 SYK (0.40) KDM4EALDH1A1KMT2AHSD17B10MAPT
SCHEMBL26575341 0.82 NPC1 (0.32) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076622-A2 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed